Table 1.
Survival of NZW rabbits following lethal B. anthracis spore challenge and levofloxacin treatment with or without concomitant AVA vaccination (rabbit PEP study)
Group | Vaccine dose | Levofloxacin treatment | Spore challenge | Survival rate |
Pa | |
---|---|---|---|---|---|---|
No. alive/total no. | % | |||||
1 | Human dose | + | + | 24/24 | 100 | <0.0001 |
2 | 1:4 | + | + | 24/24 | 100 | <0.0001 |
3 | 1:16 | + | + | 21/22b | 95.5 | <0.0001 |
4 | 1:64 | + | + | 16/23b | 69.6 | 0.0038 |
5 | Adjuvant | + | + | 5/22b | 22.7 | |
6 | None | − | + | 0/12 | 0 | |
7 | 1:4 | + | − | 23/23b | 100 | |
8 | 1:16 | + | − | 24/24 | 100 |
Compared to group 5.
Two rabbits each in groups 3 and 5, and one rabbit each in groups 4 and 7, died during the oral gavage levofloxacin administration. The death of these animals was not related to anthrax infection (which was confirmed by histopathology for the challenged animals), and these animals were excluded from the statistical analyses.